A dialysis facility in VI. It ran an operating surplus of 3.4% in FY24 on $1.3M of operating revenue. It held 39 days of cash on hand (49th percentile among dialysis facilities on liquidity). Operating margin improved from -13.2% in FY20 to 3.4% in FY24, though it fell 6.1 points in the most recent year.
Operating margin · FY24
+3.4%
▼ 6.1 pts vs FY23
vs dialysis facilities33rd pctl of 7,741
Days cash on hand · FY24
39d
all sources
▼ 35.0 days vs FY23
vs dialysis facilities49th pctl
Total operating revenue · FY24
$1.3M
▼ 0.2 $M vs FY23
vs dialysis facilities15th pctl
Total margin · incl. nonoperating · FY24
+3.4%
▼ 6.1 pts vs FY23
vs dialysis facilities33rd pctl
Where DIALYSIS 482501 sits among dialysis facilities
Operating margin · FY24 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 482501dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+3.4% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+3.4% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
39d (FY24)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
Not shown, outside plausibility bounds
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
11% (FY24)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
FY23
FY24
Patient revenue
1,729
1,585
1,342
Total operating revenue
1,729
1,585
1,342
Total operating expenses
1,342
1,434
1,296
Operating income
387
150
46
Operating margin %
+22.4%
+9.5%
+3.4%
Net income
387
150
46
Net income %
+22.4%
+9.5%
+3.4%
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Total treatments
6,424
Verified fact2024
HCRIS CMS-265
Cost per treatment ($)
201.78
Verified fact2024
HCRIS CMS-265
Net revenue per treatment ($)
208.90
Verified fact2024
HCRIS CMS-265
Trajectory
Cost-report basis · 5 reporting years
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, VI
County demographic and economic context (Census, CDC, HRSA sources) extends to this dialysis facility cohort in an upcoming release.
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
